Amgen (AMGN) announced that the U.S. FDA has approved Uplizna as the first and only treatment for adults living with Immunoglobulin G4-related disease. IgG4-RD is a chronic and debilitating immune ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of $350.00. The company’s shares closed yesterday ...

April 3 (Reuters) - The U.S. Food and Drug Administration has approved expanded use of Amgen's (AMGN.O), opens new tab drug, Uplizna, to help reduce the risk of flares in patients with a rare ...

Daniel Wiffen has predicted that he could come close to breaking world records in all three of his events at next week’s Irish Open in Dublin. The 23-year old won Olympic gold in the 800m ...

For Irish politicians, the annual trip to America to mark St. Patrick’s Day is usually about as low-risk and high-reward as anything in public life. The presentation of a bowl of shamrock had ...

Irish Olympic gold medallist Daniel Wiffen has declared that he will attempt to take down a world record at the upcoming Irish Open Swimming Championships at the National Aquatic Centre (NAC) in ...

Just 18 holes separate players from the first major championship of the season as the PGA Tour shares the stage in San Antonio with the 2025 Final Four while presenting the 2025 Texas Open.

Amgen has reported positive phase 3 results with its biosimilar version of AstraZeneca/Alexion's blockbuster rare disease drug Soliris, setting up a regulatory filing with the FDA. The biotech has ...

The 2025 Valero Texas Open is a significant event for golfers not currently invited to the Masters. Major champion Gary Woodland is among the golfers in the 2025 Valero Texas Open field who need a ...

Approval in gMG would open up a market larger than the other two combined in terms of the number of patients in the US and would help Amgen achieve its objective of building multibillion-dollar ...